The presence of driver alterations is associated with rapid development. While some alterations are enriched in CLL as compared to MBL, both equally phases share the same driver composition. (??? "???????????????????????????????????????????????"Duvelisib was the second PI3K inhibitor accredited via the FDA, also according to a phase III randomized … Read More